Corvalol (Tablets, Drops) Instructions for Use
ATC Code
N05CB02 (Barbiturates in combination with other drugs)
Active Substances
Phenobarbital (Rec.INN registered by WHO)
Ethylbromisovalerinate (Grouping name)
Clinical-Pharmacological Group
Drug with sedative and antispasmodic action
Pharmacotherapeutic Group
Psycholeptics; hypnotics and sedatives; other hypnotics and sedatives
Pharmacological Action
A combined drug, the action of which is determined by the properties of its constituent substances. It has a sedative and antispasmodic action. It facilitates the onset of natural sleep.
Phenobarbital has a vasodilating, hypnotic (in appropriate doses) and mild hypotensive effect, and enhances the sedative effect of other components.
Ethylbromisovalerinate (Ethyl ester of α-bromoisovaleric acid) has a sedative (similar to the effect of valerian) and antispasmodic action.
Peppermint oil, included in some combined drugs as an auxiliary component, has a reflex vasodilating and antispasmodic action. Some drugs contain hop cone oil or oregano oil as auxiliary components.
Indications
As a sedative and vasodilator for insomnia (difficulty falling asleep); cardialgia; sinus tachycardia; neurotic states; autonomic lability; irritability; hypochondriacal syndrome; arterial hypertension (early stages).
As an antispasmodic for spasms of the gastrointestinal tract musculature (intestinal and biliary colic).
ICD codes
| ICD-10 code | Indication |
| F45.2 | Hypochondriacal disorder |
| F45.3 | Somatoform dysfunction of the autonomic nervous system |
| F48.0 | Neurasthenia |
| F48.9 | Unspecified neurotic disorder |
| F51.0 | Nonorganic insomnia |
| I10 | Essential [primary] hypertension |
| I49.8 | Other specified cardiac arrhythmias |
| K80 | Cholelithiasis [cholelithiasis] (including biliary colic) |
| R07.2 | Pain in the heart region |
| R10.4 | Other and unspecified abdominal pain (colic) |
| R45.4 | Irritability and anger |
| ICD-11 code | Indication |
| 6A8Z | Affective disorders, unspecified |
| 6B21.0 | Dysmorphic disorder with satisfactory or preserved insight |
| 6B21.1 | Dysmorphic disorder with reduced or absent insight |
| 6B21.Z | Body dysmorphic disorder, unspecified |
| 6B23.Z | Hypochondriasis, unspecified |
| 6B6Z | Dissociative disorders, unspecified |
| 6C20.Z | Bodily distress disorder, unspecified |
| 7A00 | Chronic insomnia |
| 7A01 | Acute insomnia |
| 7A0Z | Insomnia disorders, unspecified |
| BA00.Z | Essential hypertension, unspecified |
| BC62 | Accessory pathway |
| BC65.0 | Long QT syndrome |
| BC65.1 | Brugada syndrome |
| BC65.2 | Short QT syndrome |
| BC65.3 | Early repolarization syndrome |
| BC65.4 | Idiopathic ventricular fibrillation |
| BC65.Z | Cardiac arrhythmia associated with genetic anomalies, unspecified |
| BC71.Z | Ventricular tachyarrhythmia, unspecified |
| BC81.6 | Inappropriate sinus tachycardia |
| BC81.Z | Supraventricular tachyarrhythmia, unspecified |
| BC8Z | Supraventricular arrhythmia, unspecified |
| BC90 | Atrioventricular nodal rhythm |
| BE2Y | Other specified diseases of the circulatory system |
| DC11.Z | Cholelithiasis, unspecified |
| DD93.1 | Infantile colic |
| MB24.C | Irritability |
| MC86 | Precordial pain |
| MD81.4 | Other and unspecified abdominal pain |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Drops
Take orally, before meals, after dissolving in a small amount (30-50 ml) of water.
Adults – 15-30 drops 2-3 times/day. A single dose, if necessary (for example, with tachycardia), can be increased to 40-50 drops.
Children – 3-15 drops/day (depending on age and the clinical picture of the disease).
The duration of use is determined by the doctor individually.
Tablets
Orally, before meals, 15-30 drops, after dissolving in a small amount (30-50 ml) of water, 2-3 times/day. A single dose, if necessary (for example with tachycardia), can be increased to 40-50 drops.
Children – 3-15 drops/day (depending on age and the clinical picture of the disease).
The duration of use of the drug is determined by the doctor individually.
Adverse Reactions
Possible drowsiness, dizziness, decreased ability to concentrate, allergic reactions.
With prolonged use development of chronic bromine poisoning (depression, apathy, rhinitis, conjunctivitis, hemorrhagic diathesis, impaired coordination of movements); drug dependence.
Contraindications
Severe hepatic and/or renal impairment; lactation period; hypersensitivity to the components of the drug.
With caution pregnancy.
Use in Pregnancy and Lactation
Should be used with caution during pregnancy.
If it is necessary to use during lactation, the issue of discontinuing breastfeeding should be decided.
Use in Hepatic Impairment
Contraindicated in severe hepatic impairment.
Use in Renal Impairment
Contraindicated in severe renal impairment.
Pediatric Use
The drug is approved for use in children and adolescents under 18 years of age
Special Precautions
Effect on the ability to drive vehicles and mechanisms
During the treatment period, caution should be exercised when driving vehicles and engaging in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.
Drug Interactions
Sedatives – enhancement of the effect.
Methotrexate – possible increase in methotrexate toxicity.
Neuroleptics and anxiolytics – possible enhancement of the drug’s action.
CNS stimulants – weakening of the action of each of the drug’s components.
Ethanol – enhancement of the drug’s effects and increase in its toxicity.
Antibiotics, sulfonamides – reduction of antibacterial activity due to the presence of phenobarbital in the drug composition.
Griseofulvin – decrease in the degree of absorption and, as a result, weakening of the antifungal action (due to the presence of phenobarbital in the drug composition).
Indirect anticoagulants, corticosteroids, doxycycline, estrogens and other drugs metabolized in the liver via oxidation – reduction in effectiveness, because Phenobarbital accelerates their destruction.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Oral drops: dropper bottle 15 ml, 25 ml
Marketing Authorization Holder
Altayvitamins, JSC (Russia)
Dosage Form
 |
Corvalol | Oral drops: dropper bottle 15 ml, 25 ml |
Dosage Form, Packaging, and Composition
| Oral drops | 1 ml |
| Ethyl ester of α-bromoisovaleric acid | 20 mg |
| Phenobarbital | 18.26 mg |
Excipients : ethanol 95%, sodium hydroxide, peppermint oil, purified water.
15 ml – dropper bottles (1) – cardboard packs.
25 ml – dropper bottles (1) – cardboard packs.
Oral drops: 15 or 25 ml dropper bottle
Marketing Authorization Holder
Apteka Farmikon, LLC (Russia)
Dosage Form
|
Corvalol | Oral drops: 15 or 25 ml dropper bottle |
Dosage Form, Packaging, and Composition
Oral drops in the form of a transparent colorless liquid with a specific aromatic odor.
| 1 ml | |
| Ethyl ester of α-bromoisovaleric acid | 20 mg |
| Phenobarbital | 18.26 mg |
Excipients : sodium hydroxide 3.15 g, peppermint oil 1.42 g, ethanol 95% 580 ml, purified water 420 ml.
25 ml – orange glass dropper bottles (1) – cardboard packs.
50 ml – orange glass dropper bottles (1) – cardboard packs.
Tablets: 10, 20, 30, or 50 pcs.
Marketing Authorization Holder
Aromasintez, LLC (Russia)
Manufactured By
Usolye-Sibirskiy Chemical and Pharmaceutical Plant, JSC (Russia)
Dosage Form
|
Corvalol | Tablets: 10, 20, 30, or 50 pcs. |
Dosage Form, Packaging, and Composition
Tablets white or almost white, round, flat-cylindrical, with a bevel; the presence of light gray inclusions is allowed.
| 1 tab. | |
| Ethylbromisovalerinate | 8.2 mg |
| Phenobarbital | 7.5 mg |
| Peppermint oil | 0.58 mg |
Excipients : cyclodextrin – 55.55 mg, lactose monohydrate – 43.77 mg, potato starch – 13 mg, microcrystalline cellulose type 101 – 10.5 mg, magnesium stearate – 0.9 mg.
10 pcs. – contour cell packs – cardboard packs.
10 pcs. – contour cell packs (2) – cardboard packs.
10 pcs. – contour cell packs (3) – cardboard packs.
10 pcs. – contour cell packs (5) – cardboard packs.
Tablets 0.58 mg+7.5 mg+8.2 mg: from 10 to 300 pcs.
Marketing Authorization Holder
Atoll LLC (Russia)
Manufactured By
Ozon, LLC (Russia)
Dosage Form
|
Corvalol | Tablets 0.58 mg+7.5 mg+8.2 mg: from 10 to 300 pcs. |
Dosage Form, Packaging, and Composition
Tablets round, flat-cylindrical with a bevel, almost odorless or with a faint characteristic odor; the surface of the tablets is white or white with a yellowish tint with inclusions of a darker shade.
| 1 tab. | |
| Peppermint leaf oil | 0.58 mg |
| Phenobarbital | 7.5 mg |
| Ethylbromisovalerinate | 8.2 mg |
Excipients : betadex (beta-cyclodextrin) – 55.55 mg, lactose monohydrate (milk sugar) – 26.17 mg, microcrystalline cellulose, corn starch – 13.1 mg, magnesium stearate – 0.9 mg.
10 pcs. – contour cell packs (from 1 to 10 pcs.) – cardboard packs.
20 pcs. – contour cell packs (from 1 to 10 pcs.) – cardboard packs.
30 pcs. – contour cell packs (from 1 to 10 pcs.) – cardboard packs.
Tablets: 20, 50 or 100 pcs.
Marketing Authorization Holder
Bopharm, PJSC (Russia)
Manufactured By
Pharma Start, LLC (Ukraine)
Dosage Form
|
Corvalol | Tablets: 20, 50 or 100 pcs. |
Dosage Form, Packaging, and Composition
Tablets round, flat, beveled to the edge, white or almost white, with inclusions.
| 1 tab. | |
| Peppermint oil | 580 mcg |
| Phenobarbital | 7.5 mg |
| Ethyl ester of α-bromoisovaleric acid | 8.2 mg |
Excipients : beta-cyclodextrin 55.55 mg, potato starch 13 mg, lactose monohydrate 43.77 mg, microcrystalline cellulose 10.5 mg, magnesium stearate 0.9 mg.
10 pcs. – contour cell packs (2) – cardboard packs.
10 pcs. – contour cell packs (10) – cardboard packs.
Oral drops: dropper bottle 25 ml
Marketing Authorization Holder
Dalkhimpharm, JSC (Russia)
Dosage Form
|
Corvalol | Oral drops: dropper bottle 25 ml |
Dosage Form, Packaging, and Composition
| Oral drops | 1 ml |
| Ethyl ester of α-bromoisovaleric acid | 20 mg |
| Phenobarbital | 18.26 mg |
Excipients : ethanol 95%, sodium hydroxide, peppermint oil, purified water.
25 ml – dropper bottles.
Oral drops: 25 ml dropper bottle.
Marketing Authorization Holder
Genel RD, LLC (Russia)
Dosage Form
|
Corvalol | Oral drops: 25 ml dropper bottle. |
Dosage Form, Packaging, and Composition
| Oral drops | 1 ml |
| Ethyl ester of α-bromoisovaleric acid | 20 mg |
| Phenobarbital | 18.26 mg |
Excipients : ethanol 95%, sodium hydroxide, peppermint oil, purified water.
25 ml – dropper bottles (1) – cardboard packs.
Oral drops: 25 ml dropper bottle.
Marketing Authorization Holder
Genel RD, LLC (Russia)
Dosage Form
|
Corvalol | Oral drops: 25 ml dropper bottle. |
Dosage Form, Packaging, and Composition
| Oral drops | 1 ml |
| Ethyl ester of α-bromoisovaleric acid | 20 mg |
| Phenobarbital | 18.26 mg |
Excipients : ethanol 95%, sodium hydroxide, peppermint oil, purified water.
25 ml – dropper bottles (1) – cardboard packs.
Oral drops: dropper bottle 15 ml, 25 ml, 30 ml, or 50 ml
Marketing Authorization Holder
Kirov Pharmaceutical Factory, SUE (Russia)
Dosage Form
|
Corvalol | Oral drops: dropper bottle 15 ml, 25 ml, 30 ml, or 50 ml |
Dosage Form, Packaging, and Composition
| Oral drops | 1 ml |
| Ethyl ester of α-bromoisovaleric acid | 20 mg |
| Phenobarbital | 18.26 mg |
| Peppermint leaf oil | 1.42 mg |
Excipients: ethanol 95%, sodium hydroxide, purified water.
15 ml – dark glass dropper bottle (1) – cardboard packs.
25 ml – dark glass dropper bottle (1) – cardboard packs.
30 ml – dark glass dropper bottle (1) – cardboard packs.
50 ml – dark glass dropper bottle (1) – cardboard packs.
Oral drops: dropper bottle 25 ml
Marketing Authorization Holder
Marbiopharm, JSC (Russia)
Dosage Form
|
Corvalol | Oral drops: dropper bottle 25 ml |
Dosage Form, Packaging, and Composition
| Oral drops | 1 ml |
| Ethyl ester of α-bromoisovaleric acid | 20 mg |
| Phenobarbital | 18.26 mg |
Excipients: ethanol 95%, sodium hydroxide, peppermint oil, purified water.
25 ml – dropper bottle.
Oral drops: dropper bottle 15 ml or 25 ml
Marketing Authorization Holder
Murom Instrument-Making Plant, JSC (Russia)
Dosage Form
|
Corvalol | Oral drops: dropper bottle 15 ml or 25 ml |
Dosage Form, Packaging, and Composition
Oral drops transparent, colorless, with a specific aromatic odor.
| 1 ml | |
| Ethylbromisovalerinate | 20 mg |
| Phenobarbital | 18.26 mg |
| Peppermint leaf oil | 1.42 mg |
Excipients: sodium hydroxide – 3.15 g, ethanol 95% – 580 ml, purified water – 420 ml.
15 ml – dark glass dropper bottle (1) – cardboard packs.
25 ml – dark glass dropper bottle (1) – cardboard packs.
Oral drops: dropper bottle 15 ml, 25 ml
Marketing Authorization Holder
Institute Of Medicine And Standardization, LLC (Russia)
Dosage Form
|
Corvalol | Oral drops: dropper bottle 15 ml, 25 ml |
Dosage Form, Packaging, and Composition
| Oral drops | 1 ml |
| Ethyl ester of α-bromoisovaleric acid | 20 mg |
| Phenobarbital | 18.26 mg |
Excipients: ethanol 95%, sodium hydroxide, peppermint oil, purified water.
15 ml – dropper bottle (1) – cardboard packs.
25 ml – dropper bottle (1) – cardboard packs.
Oral drops: 15 ml or 25 ml dropper bottles.
Marketing Authorization Holder
Permpharmacy, PJSC (Russia)
Dosage Form
|
Corvalol | Oral drops: 15 ml or 25 ml dropper bottles. |
Dosage Form, Packaging, and Composition
| Oral drops | 1 ml |
| Ethyl ester of α-bromoisovaleric acid | 20 mg |
| Phenobarbital | 18.26 mg |
Excipients: ethanol 95%, sodium hydroxide, peppermint oil, purified water.
15 ml – dropper bottle.
25 ml – dropper bottle.
Oral drops: 15 ml or 25 ml dropper bottles.
Marketing Authorization Holder
Rostov Pharmaceutical Factory, CJSC (Russia)
Dosage Form
|
Corvalol | Oral drops: 15 ml or 25 ml dropper bottles. |
Dosage Form, Packaging, and Composition
| Oral drops | 1 ml |
| Ethyl ester of α-bromoisovaleric acid | 20 mg |
| Phenobarbital | 18.26 mg |
Excipients: ethanol 95%, sodium hydroxide, peppermint oil, purified water.
15 ml – dropper bottle.
25 ml – dropper bottle.
Oral drops: dropper bottles 15, 25, or 50 ml
Marketing Authorization Holder
Sesana, CJS (Russia)
Dosage Form
|
Corvalol | Oral drops: dropper bottles 15, 25, or 50 ml |
Dosage Form, Packaging, and Composition
| Oral drops | 1 ml |
| Ethyl ester of α-bromoisovaleric acid | 20 mg |
| Phenobarbital | 18.26 mg |
Excipients: ethanol 95%, sodium hydroxide, peppermint oil, purified water.
15 ml – dropper bottle (1) – cardboard packs.
25 ml – dropper bottle (1) – cardboard packs.
50 ml – dropper bottle (1) – cardboard packs.
Oral drops: 15 ml or 25 ml dropper bottles.
Marketing Authorization Holder
Tatkhimpharmpreparaty, JSC (Russia)
Dosage Form
|
Corvalol | Oral drops: 15 ml or 25 ml dropper bottles. |
Dosage Form, Packaging, and Composition
| Oral drops | 1 ml |
| Ethyl ester of α-bromoisovaleric acid | 20 mg |
| Phenobarbital | 18.26 mg |
Excipients: ethanol 95%, sodium hydroxide, peppermint oil, purified water.
15 ml – dropper bottle.
25 ml – dropper bottle.
Oral drops: 15 ml or 25 ml dropper bottles.
Marketing Authorization Holder
Tver Pharmaceutical Factory, PJSC (Russia)
Dosage Form
|
Corvalol | Oral drops: 15 ml or 25 ml dropper bottles. |
Dosage Form, Packaging, and Composition
| Oral drops | 1 ml |
| Ethyl ester of α-bromoisovaleric acid | 20 mg |
| Phenobarbital | 18.26 mg |
Excipients: ethanol 95%, sodium hydroxide, peppermint oil, purified water.
15 ml – dropper bottle.
25 ml – dropper bottle.
Oral drops: 25 or 50 ml dropper bottle
Marketing Authorization Holder
Usolye-Sibirskiy Chemical and Pharmaceutical Plant, JSC (Russia)
Dosage Form
|
Corvalol | Oral drops: 25 or 50 ml dropper bottle |
Dosage Form, Packaging, and Composition
| Oral drops | 100 ml |
| Ethyl ester of α-bromoisovaleric acid | 2 g |
| Phenobarbital | 1.826 g |
| Peppermint oil | 0.142 g |
Excipients: ethanol 95% – 58 ml, sodium hydroxide – 0.315 g, purified water – up to 100 ml.
25 ml – dark glass dropper bottle (1) – cardboard packs.
50 ml – dark glass dropper bottle (1) – cardboard packs.
Oral drops: 15 ml or 25 ml dropper bottles.
Marketing Authorization Holder
Farmak, JSC (Ukraine)
Dosage Form
|
Corvalol | Oral drops: 15 ml or 25 ml dropper bottles. |
Dosage Form, Packaging, and Composition
| Oral drops | 1 ml |
| Ethyl ester of α-bromoisovaleric acid | 20 mg |
| Phenobarbital | 18.26 mg |
| Peppermint oil | 1.42 mg |
Excipients: ethanol 95%, sodium hydroxide, purified water.
15 ml – dark glass dropper bottle (1) – cardboard packs.
25 ml – dark glass dropper bottle (1) – cardboard packs.
Oral drops: dropper bottle 15 ml or 25 ml
Marketing Authorization Holder
Pharmstandard-Lexredstva OJSC (Russia)
Dosage Form
|
Corvalol | Oral drops: dropper bottle 15 ml or 25 ml |
Dosage Form, Packaging, and Composition
Oral drops in the form of a transparent, colorless liquid, with a characteristic odor.
| 1 ml | |
| Ethylbromisovalerinate | 20 mg |
| Phenobarbital | 18.26 mg |
| Peppermint leaf oil | 1.42 mg |
Excipients: ethyl alcohol (ethanol) 95% – 0.79 ml, sodium hydroxide – 0.22 mg, purified water – up to 1 ml.
15 ml – dark glass dropper bottle (1) – cardboard packs.
25 ml – dark glass dropper bottle (1) – cardboard packs.
Tablets: 10, 20, 30, 40, or 50 pcs.
Marketing Authorization Holder
Pharmstandard-Lexredstva OJSC (Russia)
Dosage Form
|
Corvalol | Tablets: 10, 20, 30, 40, or 50 pcs. |
Dosage Form, Packaging, and Composition
Tablets white or almost white, round, flat-cylindrical, with inclusions, with a bevel and a score.
| 1 tab. | |
| Peppermint oil | 580 mcg |
| Phenobarbital | 7.5 mg |
| Ethyl ester of α-bromoisovaleric acid | 8.2 mg |
Excipients: betadex (beta-cyclodextrin) – 55.55 mg, potato starch – 37.57 mg, lactose monohydrate (milk sugar) – 83.7 mg, magnesium aluminometasilicate (neusilin UFL 2) – 4 mg, talc – 2 mg, magnesium stearate – 0.9 mg.
10 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (2) – cardboard packs.
10 pcs. – contour cell packs (3) – cardboard packs.
10 pcs. – contour cell packs (4) – cardboard packs.
10 pcs. – contour cell packs (5) – cardboard packs.
Oral drops: 15 ml or 25 ml bottle
Marketing Authorization Holder
Flora Kavkaza, JSC (Russia)
Dosage Form
|
Corvalol | Oral drops: 15 ml or 25 ml bottle |
Dosage Form, Packaging, and Composition
Oral drops in the form of a transparent, colorless liquid, with a characteristic odor.
| 100 ml | |
| Ethylbromisovalerinate | 2 g |
| Phenobarbital | 1.826 g |
| Peppermint oil | 0.142 g |
Excipients: sodium hydroxide – 0.315 g, ethanol 95% – 58 ml, purified water – up to 100 ml.
15 ml – bottle – cardboard packs.
25 ml – bottle – cardboard packs.
Oral drops: 15 ml or 25 ml dropper bottles.
Marketing Authorization Holder
Ecolab, CJS (Russia)
Dosage Form
|
Corvalol | Oral drops: 15 ml or 25 ml dropper bottles. |
Dosage Form, Packaging, and Composition
| Oral drops | 1 ml |
| Ethyl ester of α-bromoisovaleric acid | 20 mg |
| Phenobarbital | 18.26 mg |
Excipients: ethanol 95%, sodium hydroxide, peppermint oil, purified water.
15 ml – dropper bottle (1) – cardboard packs.
25 ml – dropper bottle (1) – cardboard packs.
Tablets: 10, 20, 30, 40, 50, 60, 80, or 100 pcs.
Marketing Authorization Holder
YUGPHARM, LLC (Russia)
Dosage Form
|
Corvalol | Tablets: 10, 20, 30, 40, 50, 60, 80, or 100 pcs. |
Dosage Form, Packaging, and Composition
Tablets white or almost white, with inclusions, round in shape, flat-cylindrical, beveled to the edge with chamfers.
| 1 tab. | |
| Peppermint leaf oil | 0.58 mg |
| Phenobarbital | 7.5 mg |
| Ethylbromisovalerinate | 8.2 mg |
Excipients: β-cyclodextrin, corn starch, lactose monohydrate, microcrystalline cellulose, magnesium stearate.
10 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (2) – cardboard packs.
10 pcs. – contour cell packs (3) – cardboard packs.
10 pcs. – contour cell packs (4) – cardboard packs.
10 pcs. – contour cell packs (5) – cardboard packs.
20 pcs. – contour cell packs (1) – cardboard packs.
20 pcs. – contour cell packs (2) – cardboard packs.
20 pcs. – contour cell packs (3) – cardboard packs.
20 pcs. – contour cell packs (4) – cardboard packs.
20 pcs. – contour cell packs (5) – cardboard packs.
Oral drops: dropper bottle 15 ml or 25 ml
Marketing Authorization Holder
Yaroslavl Pharmaceutical Factory, CJSC (Russia)
Dosage Form
|
Corvalol | Oral drops: dropper bottle 15 ml or 25 ml |
Dosage Form, Packaging, and Composition
| Oral drops | 1 ml |
| Ethyl ester of α-bromoisovaleric acid | 20 mg |
| Phenobarbital | 18.26 mg |
| Peppermint leaf oil | 1.42 mg |
15 ml – dark glass dropper bottle (1) – cardboard packs.
25 ml – dark glass dropper bottle (1) – cardboard packs.
![Corvalol [Tablets, Drops] 1](https://www.medixlife.com/wp-content/uploads/Medixlife_favi_512.png "Corvalol [Tablets, Drops] 2")